PMC:7289100 / 11739-12171 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T179","span":{"begin":17,"end":45},"obj":"Disease"},{"id":"T180","span":{"begin":54,"end":82},"obj":"Disease"},{"id":"T181","span":{"begin":63,"end":82},"obj":"Disease"},{"id":"T182","span":{"begin":84,"end":87},"obj":"Disease"},{"id":"T183","span":{"begin":123,"end":133},"obj":"Disease"},{"id":"T184","span":{"begin":338,"end":356},"obj":"Disease"},{"id":"T185","span":{"begin":387,"end":420},"obj":"Disease"},{"id":"T186","span":{"begin":395,"end":420},"obj":"Disease"},{"id":"T187","span":{"begin":422,"end":425},"obj":"Disease"}],"attributes":[{"id":"A179","pred":"mondo_id","subj":"T179","obj":"http://purl.obolibrary.org/obo/MONDO_0015939"},{"id":"A180","pred":"mondo_id","subj":"T180","obj":"http://purl.obolibrary.org/obo/MONDO_0007915"},{"id":"A181","pred":"mondo_id","subj":"T181","obj":"http://purl.obolibrary.org/obo/MONDO_0004670"},{"id":"A182","pred":"mondo_id","subj":"T182","obj":"http://purl.obolibrary.org/obo/MONDO_0007915"},{"id":"A183","pred":"mondo_id","subj":"T183","obj":"http://purl.obolibrary.org/obo/MONDO_0000831"},{"id":"A184","pred":"mondo_id","subj":"T184","obj":"http://purl.obolibrary.org/obo/MONDO_0007179"},{"id":"A185","pred":"mondo_id","subj":"T185","obj":"http://purl.obolibrary.org/obo/MONDO_0005204"},{"id":"A186","pred":"mondo_id","subj":"T186","obj":"http://purl.obolibrary.org/obo/MONDO_0007140"},{"id":"A187","pred":"mondo_id","subj":"T187","obj":"http://purl.obolibrary.org/obo/MONDO_0017278"},{"id":"A188","pred":"mondo_id","subj":"T187","obj":"http://purl.obolibrary.org/obo/MONDO_0007140"}],"text":"In patients with systemic autoimmune diseases such as Systemic Lupus Erythematosus (SLE), aPL represent the major cause of thrombosis (either arterial or venous or microangiopathic) and pregnancy morbidity. aPL are pathogenic autoantibodies that can cause the same vascular and obstetric manifestations also in subjects without any other autoimmune disease, suffering from the so called Primary Antiphospholipid Syndrome (APS) [43]."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T109","span":{"begin":142,"end":150},"obj":"http://purl.obolibrary.org/obo/UBERON_0001637"},{"id":"T110","span":{"begin":142,"end":150},"obj":"http://www.ebi.ac.uk/efo/EFO_0000814"}],"text":"In patients with systemic autoimmune diseases such as Systemic Lupus Erythematosus (SLE), aPL represent the major cause of thrombosis (either arterial or venous or microangiopathic) and pregnancy morbidity. aPL are pathogenic autoantibodies that can cause the same vascular and obstetric manifestations also in subjects without any other autoimmune disease, suffering from the so called Primary Antiphospholipid Syndrome (APS) [43]."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T50","span":{"begin":422,"end":425},"obj":"Chemical"}],"attributes":[{"id":"A50","pred":"chebi_id","subj":"T50","obj":"http://purl.obolibrary.org/obo/CHEBI_17709"}],"text":"In patients with systemic autoimmune diseases such as Systemic Lupus Erythematosus (SLE), aPL represent the major cause of thrombosis (either arterial or venous or microangiopathic) and pregnancy morbidity. aPL are pathogenic autoantibodies that can cause the same vascular and obstetric manifestations also in subjects without any other autoimmune disease, suffering from the so called Primary Antiphospholipid Syndrome (APS) [43]."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T97","span":{"begin":26,"end":45},"obj":"Phenotype"},{"id":"T98","span":{"begin":54,"end":82},"obj":"Phenotype"},{"id":"T99","span":{"begin":84,"end":87},"obj":"Phenotype"},{"id":"T100","span":{"begin":90,"end":93},"obj":"Phenotype"},{"id":"T101","span":{"begin":207,"end":210},"obj":"Phenotype"},{"id":"T102","span":{"begin":338,"end":356},"obj":"Phenotype"}],"attributes":[{"id":"A97","pred":"hp_id","subj":"T97","obj":"http://purl.obolibrary.org/obo/HP_0002960"},{"id":"A98","pred":"hp_id","subj":"T98","obj":"http://purl.obolibrary.org/obo/HP_0002725"},{"id":"A99","pred":"hp_id","subj":"T99","obj":"http://purl.obolibrary.org/obo/HP_0002725"},{"id":"A100","pred":"hp_id","subj":"T100","obj":"http://purl.obolibrary.org/obo/HP_0003613"},{"id":"A101","pred":"hp_id","subj":"T101","obj":"http://purl.obolibrary.org/obo/HP_0003613"},{"id":"A102","pred":"hp_id","subj":"T102","obj":"http://purl.obolibrary.org/obo/HP_0002960"}],"text":"In patients with systemic autoimmune diseases such as Systemic Lupus Erythematosus (SLE), aPL represent the major cause of thrombosis (either arterial or venous or microangiopathic) and pregnancy morbidity. aPL are pathogenic autoantibodies that can cause the same vascular and obstetric manifestations also in subjects without any other autoimmune disease, suffering from the so called Primary Antiphospholipid Syndrome (APS) [43]."}

{"project":"LitCovid-sentences","denotations":[{"id":"T79","span":{"begin":0,"end":432},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"In patients with systemic autoimmune diseases such as Systemic Lupus Erythematosus (SLE), aPL represent the major cause of thrombosis (either arterial or venous or microangiopathic) and pregnancy morbidity. aPL are pathogenic autoantibodies that can cause the same vascular and obstetric manifestations also in subjects without any other autoimmune disease, suffering from the so called Primary Antiphospholipid Syndrome (APS) [43]."}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T203","span":{"begin":26,"end":36},"obj":"UBERON:0002405"},{"id":"T204","span":{"begin":123,"end":133},"obj":"GO:0007596"},{"id":"T205","span":{"begin":142,"end":150},"obj":"UBERON:0001637"},{"id":"T206","span":{"begin":154,"end":160},"obj":"UBERON:0001638"},{"id":"T207","span":{"begin":186,"end":195},"obj":"GO:0007565"},{"id":"T208","span":{"begin":226,"end":240},"obj":"GO:0042571"},{"id":"T209","span":{"begin":338,"end":348},"obj":"UBERON:0002405"},{"id":"T210","span":{"begin":422,"end":425},"obj":"PR:000003015"},{"id":"T69221","span":{"begin":26,"end":36},"obj":"UBERON:0002405"},{"id":"T35155","span":{"begin":123,"end":133},"obj":"GO:0007596"},{"id":"T7661","span":{"begin":142,"end":150},"obj":"UBERON:0001637"},{"id":"T69640","span":{"begin":154,"end":160},"obj":"UBERON:0001638"},{"id":"T30560","span":{"begin":186,"end":195},"obj":"GO:0007565"},{"id":"T73087","span":{"begin":226,"end":240},"obj":"GO:0042571"},{"id":"T13894","span":{"begin":338,"end":348},"obj":"UBERON:0002405"},{"id":"T76258","span":{"begin":422,"end":425},"obj":"PR:000003015"}],"text":"In patients with systemic autoimmune diseases such as Systemic Lupus Erythematosus (SLE), aPL represent the major cause of thrombosis (either arterial or venous or microangiopathic) and pregnancy morbidity. aPL are pathogenic autoantibodies that can cause the same vascular and obstetric manifestations also in subjects without any other autoimmune disease, suffering from the so called Primary Antiphospholipid Syndrome (APS) [43]."}

{"project":"LitCovid-PubTator","denotations":[{"id":"440","span":{"begin":3,"end":11},"obj":"Species"},{"id":"448","span":{"begin":26,"end":45},"obj":"Disease"},{"id":"449","span":{"begin":54,"end":82},"obj":"Disease"},{"id":"450","span":{"begin":84,"end":87},"obj":"Disease"},{"id":"451","span":{"begin":90,"end":93},"obj":"Disease"},{"id":"452","span":{"begin":123,"end":133},"obj":"Disease"},{"id":"453","span":{"begin":207,"end":210},"obj":"Disease"},{"id":"454","span":{"begin":338,"end":356},"obj":"Disease"},{"id":"455","span":{"begin":387,"end":420},"obj":"Disease"},{"id":"456","span":{"begin":422,"end":425},"obj":"Disease"}],"attributes":[{"id":"A440","pred":"tao:has_database_id","subj":"440","obj":"Tax:9606"},{"id":"A448","pred":"tao:has_database_id","subj":"448","obj":"MESH:D001327"},{"id":"A449","pred":"tao:has_database_id","subj":"449","obj":"MESH:D008180"},{"id":"A450","pred":"tao:has_database_id","subj":"450","obj":"MESH:D008180"},{"id":"A452","pred":"tao:has_database_id","subj":"452","obj":"MESH:D013927"},{"id":"A454","pred":"tao:has_database_id","subj":"454","obj":"MESH:D001327"},{"id":"A455","pred":"tao:has_database_id","subj":"455","obj":"MESH:D016736"},{"id":"A456","pred":"tao:has_database_id","subj":"456","obj":"MESH:D016884"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"In patients with systemic autoimmune diseases such as Systemic Lupus Erythematosus (SLE), aPL represent the major cause of thrombosis (either arterial or venous or microangiopathic) and pregnancy morbidity. aPL are pathogenic autoantibodies that can cause the same vascular and obstetric manifestations also in subjects without any other autoimmune disease, suffering from the so called Primary Antiphospholipid Syndrome (APS) [43]."}

{"project":"2_test","denotations":[{"id":"32535093-27421221-4828864","span":{"begin":428,"end":430},"obj":"27421221"}],"text":"In patients with systemic autoimmune diseases such as Systemic Lupus Erythematosus (SLE), aPL represent the major cause of thrombosis (either arterial or venous or microangiopathic) and pregnancy morbidity. aPL are pathogenic autoantibodies that can cause the same vascular and obstetric manifestations also in subjects without any other autoimmune disease, suffering from the so called Primary Antiphospholipid Syndrome (APS) [43]."}